Home › Funds › Clearwater Capital Advisors, LLC › IBRX

Clearwater Capital Advisors, LLC position in IBRX

IMMUNITYBIO INC · Health Care

Clearwater Capital Advisors, LLC reported holding 717,524 shares of IBRX (IMMUNITYBIO INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.49% of its reported portfolio and ranking #35 among its reported holdings. Clearwater Capital Advisors, LLC has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)717.52K sh
Reported value held$6.77M
Portfolio Weight0.49%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Clearwater Capital Advisors, LLC's IBRX position evolved

Clearwater Capital Advisors, LLC first disclosed a stake in IBRX in Q3 2023 at 394,599 shares (US$667K). The position peaked in Q3 2026 at 717,524 shares, worth US$6.8M. Across 13 filings, Clearwater Capital Advisors, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 717,524 shares valued at US$6.8M. Notable position changes include a 75% increase in Q4 2024 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 394.60K $666.87K New
Q4 2023 443.30K $2.23M Add
Q1 2024 443.30K $2.38M Hold
Q2 2024 482.55K $3.05M Add
Q3 2024 482.55K $1.80M Hold
Q4 2024 846.42K $2.17M Add
Q1 2025 846.42K $2.55M Hold
Q2 2025 846.42K $2.23M Hold
Q3 2025 846.42K $2.08M Hold
Q4 2025 845.08K $1.67M Hold
Q1 2026 717.52K $5.50M Reduce
Q2 2026 717.52K $6.28M Hold
Q3 2026 717.52K $6.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBRX and 13F data

IBRX (IMMUNITYBIO INC) is a Health Care company. 66 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), Sound Capital Solutions LLC (US$9.8M), ALLEN HOLDING INC /NY (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBRX

All IBRX fund holders →

FAQ

How long has Clearwater Capital Advisors, LLC held IBRX?

Clearwater Capital Advisors, LLC has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Clearwater Capital Advisors, LLC's current position in IBRX?

As of Q3 2026, Clearwater Capital Advisors, LLC holds 717.52K shares of IBRX (IMMUNITYBIO INC), valued at $6.77M, representing 0.49% of its reported portfolio and ranking #35.

Has Clearwater Capital Advisors, LLC been buying or selling IBRX?

In the latest 13F filing (Q3 2026), Clearwater Capital Advisors, LLC held unchanged its position in IBRX. The position peaked in Q3 2026 at 717.52K shares.

Which other funds hold IBRX?

Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, Sound Capital Solutions LLC, ALLEN HOLDING INC /NY, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.